CLINICAL_TRIALS
trial_result
· 2016-02-05
Clinical Trial Update: Nicotinic Receptors and Schizophrenia [Phase 1]
Summary
Phase 1 trial evaluating nicotinic receptor targets in schizophrenia. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: VA Office of Research and Development | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2016-02-05